Celebrating Progress, but Challenges Remain
January 30th 2020With their early age of onset, high prevalence, chronicity, and pervasive impact on multiple domains of functioning, the burden of mood disorders exceeds that of virtually all medical conditions in the US and globally in terms of disability, cost, and suffering.
Integrating Psychotherapy and Psychopharmacology in the Treatment of Major Depressive Disorder
January 30th 2020Although multiple interventions exist for major depressive disorder (MDD), only partial response is achieved in many patients and recurrence is common. Combining medication and psychotherapy may enable more effective treatment of MDD.
Novel Approaches to Bipolar: What Worked, and What Did Not, in 2019
January 30th 2020The first part of this series covered updates on traditional psychotropics-lithium, anticonvulsants, antipsychotics, and more. Here, Part 2 examines anti-inflammatories, natural supplements, and mitochondrial therapies.
Autoimmune Encephalitis: What Psychiatrists Need to Know
January 29th 2020This article broadly reviews the pathophysiology of the most common forms of autoimmune encephalitis and provides guidelines tailored toward mental health professionals to best identify and manage these rare but important causes of neuropsychiatric illness.
The Opening of the Maudsley Hospital: January 31, 1923
January 29th 2020In the early years, treatment was largely restricted to restraint and sedation with great emphasis placed on fresh air for prevention of mental illness. Later, the aim of treatment was to prevent transfer of patients to country asylums.
Detecting Agitation in Patients With Dementia and Alzheimer Disease
January 27th 2020In this video, Marc E. Agronin, MD, discusses several factors that may play a role in agitation. One would be underlying medical causes. It could be an acute disease state impairing brain function. And the list goes on.
The Postmodern Assumptions of the Biopsychosocial Approach
January 27th 2020Early on, psychiatry accepted the idea that unconscious psychology affected the body to cause disease. By the 1970s, the rise of psychiatric drugs pushed the field in a biological direction, and by the 1980s, psychoanalysis was in full retreat, at least in the halls of psychiatric power. S. Nassir Ghaemi, MD, adds to the debate.